
CVRx, Inc.: shareholders and insiders
Price
$0.60
November 18, 2026Market cap $17M
What Ploutos Investor adds for CVRx
Part of Ploutos Investor, €9.99 a month
- The full history: 6 fiscal years, from 2020
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 59% since Nov 5, 2026, when the 10-Q these figures come from was filed ($1.47 then, $0.60 on Nov 18, 2026). The figures date from before that move.10-Q
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
Insiders and their shares
Purchases and sales by officers and directors from Nov 19, 2025 to Nov 12, 2026, from their own Form 4 filings.
Bought on the market
$376.9K
2 people
Sold on the market
$444.6K
8 people
From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan29%
- The rest71%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 19, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $376.7K by 2 people·sold $129.9K by 6 people
- 2025: no buys, sold $314.7K by 2 people
- 2026: bought $376.7K by 2 people, sold $129.9K by 6 people
- Nov 9, 2026John LandryChief Financial OfficerKind
- Aug 13, 2026Brent BinkowskiCHIEF OPERATING OFFICERKind
- Aug 12, 2026Brent BinkowskiCHIEF OPERATING OFFICERKind10b5-1
- Jun 1, 2026Kirk G. NielsenDirectorKind
- Jun 1, 2026Mudit K. JainDirectorKind
- Jun 1, 2026Joseph P SlatteryDirectorKind
- Jun 1, 2026Hill, Mitch C.DirectorKind
- Jun 1, 2026Kevin J. BallingerDirectorKind
- Jun 1, 2026Martha ShadanDirectorKind
- Jun 1, 2026Michael D DaleDirectorKind
- Mar 2, 2026Philip B. AdamsonChief Medical OfficerKind10b5-1
- Mar 2, 2026Kevin HykesPRES & CEOKind10b5-1
- Mar 2, 2026Jared OasheimCHIEF FINANCIAL OFFICERKind10b5-1
- Mar 2, 2026Paul VerrastroCHIEF MKTG & STRAT OFFICERKind10b5-1
- Mar 2, 2026Robert Allen JohnChief Revenue OfficerKind10b5-1
- Feb 20, 2026Mudit K. JainKind
- Feb 18, 2026Mudit K. JainKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | John LandryChief Financial Officer | 41.4K | – | – | Form 4 | |
| Aug 13, 2026 | Brent BinkowskiCHIEF OPERATING OFFICER | 26.2K | $2.91 | $76.4K | Form 4 | |
| Aug 12, 2026 | Brent BinkowskiCHIEF OPERATING OFFICER | 10b5-1 | 1,309 | $2.55 | $3.3K | Form 4 |
| Jun 1, 2026 | Kirk G. NielsenDirector | 8,720 | – | – | Form 4 | |
| Jun 1, 2026 | Mudit K. JainDirector | 8,720 | – | – | Form 4 | |
| Jun 1, 2026 | Joseph P SlatteryDirector | 8,720 | – | – | Form 4 | |
| Jun 1, 2026 | Hill, Mitch C.Director | 8,720 | – | – | Form 4 | |
| Jun 1, 2026 | Kevin J. BallingerDirector | 8,720 | – | – | Form 4 | |
| Jun 1, 2026 | Martha ShadanDirector | 8,720 | – | – | Form 4 | |
| Jun 1, 2026 | Michael D DaleDirector | 29.0K | – | – | Form 4 | |
| Mar 2, 2026 | Philip B. AdamsonChief Medical Officer | 10b5-1 | 1,262 | $7.90 | $10.0K | Form 4 |
| Mar 2, 2026 | Kevin HykesPRES & CEO | 10b5-1 | 7,763 | $7.90 | $61.3K | Form 4 |
| Mar 2, 2026 | Jared OasheimCHIEF FINANCIAL OFFICER | 10b5-1 | 1,744 | $7.90 | $13.8K | Form 4 |
| Mar 2, 2026 | Paul VerrastroCHIEF MKTG & STRAT OFFICER | 10b5-1 | 1,284 | $7.90 | $10.1K | Form 4 |
| Mar 2, 2026 | Robert Allen JohnChief Revenue Officer | 10b5-1 | 3,964 | $7.90 | $31.3K | Form 4 |
| Feb 20, 2026 | Mudit K. Jain | 46.8K | $6.36 | $297.6K | Form 4 | |
| Feb 18, 2026 | Mudit K. Jain | 600 | $4.64 | $2.8K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 3, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by CVRX's officers and directors from 2021 up to November 18, 2025, 5 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Johnson & Johnsonwith 1 more personShare of class15.4%
- New Enterprise Associates 10, Limited Partnershipwith 7 more personsShare of class7.80%
- Vensana Capital I GP, LLCwith 3 more personsShare of class7.20%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Johnson & Johnsonwith 1 more person | 15.4% | 4.02M | Jan 12, 2026 | 13G/A | |
| New Enterprise Associates 10, Limited Partnershipwith 7 more persons | 7.80% | 2.03M | Feb 20, 2025 | 13D/A | |
| Vensana Capital I GP, LLCwith 3 more persons | 7.20% | 1.76M | Feb 6, 2025 | 13G/A |
Fell to 5% or less (2)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Point72 (Cohen)In the quarter
- Citadel Advisors (Griffin)In the quarter+726%
- Millennium Mgmt (Englander)In the quarter
- D.E. ShawIn the quarter
- Renaissance TechnologiesIn the quarter+89%
- AQR CapitalIn the quarter+14%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Point72 (Cohen) | – | – | 0.00% | |
| Citadel Advisors (Griffin) | 652.4K | +726% | $1.1M | 0.00% |
| Millennium Mgmt (Englander) | – | – | 0.00% | |
| D.E. Shaw | 200.8K | $400.0K | 0.00% | |
| Renaissance Technologies | 435.4K | +89% | $800.0K | 0.00% |
| AQR Capital | 120.6K | +14% | $200.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 7.50% of its shares outstanding were held short, +7.8% since the report before.
- Shares held short
- 2.14M
- 7.50%
- Since the report before1.98M on Sep 30, 2026
- +7.8%
- 3.1
- 691.1K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 36%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 773.2K
- Nov 15, 2023: Shares held short 695.4K
- Nov 30, 2023: Shares held short 670.6K
- Dec 15, 2023: Shares held short 671.9K
- Dec 29, 2023: Shares held short 417.7K
- Jan 12, 2024: Shares held short 362.2K
- Jan 31, 2024: Shares held short 479.5K
- Feb 15, 2024: Shares held short 596.3K
- Feb 29, 2024: Shares held short 671.2K
- Mar 15, 2024: Shares held short 781.3K
- Mar 28, 2024: Shares held short 830.8K
- Apr 15, 2024: Shares held short 786.5K
- Apr 30, 2024: Shares held short 870.2K
- May 15, 2024: Shares held short 877.2K
- May 31, 2024: Shares held short 1.11M
- Jun 14, 2024: Shares held short 1.55M
- Jun 28, 2024: Shares held short 2.06M
- Jul 15, 2024: Shares held short 2.15M
- Jul 31, 2024: Shares held short 2.21M
- Aug 15, 2024: Shares held short 2.32M
- Aug 30, 2024: Shares held short 2.29M
- Sep 13, 2024: Shares held short 2.02M
- Sep 30, 2024: Shares held short 1.99M
- Oct 15, 2024: Shares held short 2.40M
- Oct 31, 2024: Shares held short 2.52M
- Nov 15, 2024: Shares held short 2.06M
- Nov 29, 2024: Shares held short 1.95M
- Dec 13, 2024: Shares held short 1.95M
- Dec 31, 2024: Shares held short 1.96M
- Jan 15, 2025: Shares held short 2.04M
- Jan 31, 2025: Shares held short 1.84M
- Feb 14, 2025: Shares held short 1.93M
- Feb 28, 2025: Shares held short 2.19M
- Mar 14, 2025: Shares held short 2.27M
- Mar 31, 2025: Shares held short 2.28M
- Apr 15, 2025: Shares held short 1.22M
- Apr 30, 2025: Shares held short 1.24M
- May 15, 2025: Shares held short 1.48M
- May 30, 2025: Shares held short 1.49M
- Jun 13, 2025: Shares held short 1.65M
- Jun 30, 2025: Shares held short 1.78M
- Jul 15, 2025: Shares held short 1.79M
- Jul 31, 2025: Shares held short 1.98M
- Aug 15, 2025: Shares held short 1.94M
- Aug 29, 2025: Shares held short 1.91M
- Sep 15, 2025: Shares held short 1.87M
- Sep 30, 2025: Shares held short 1.84M
- Oct 15, 2025: Shares held short 1.80M
- Oct 31, 2025: Shares held short 1.70M
- Nov 14, 2025: Shares held short 1.50M
- Nov 28, 2025: Shares held short 1.49M
- Dec 15, 2025: Shares held short 1.49M
- Dec 31, 2025: Shares held short 1.34M
- Jan 15, 2026: Shares held short 1.33M
- Jan 30, 2026: Shares held short 1.64M
- Feb 13, 2026: Shares held short 1.51M
- Feb 27, 2026: Shares held short 1.93M
- Mar 13, 2026: Shares held short 1.79M
- Mar 31, 2026: Shares held short 1.69M
- Apr 15, 2026: Shares held short 1.67M
- Apr 30, 2026: Shares held short 1.75M
- May 15, 2026: Shares held short 1.91M
- May 29, 2026: Shares held short 1.94M
- Jun 15, 2026: Shares held short 1.76M
- Jun 30, 2026: Shares held short 1.84M
- Jul 15, 2026: Shares held short 1.93M
- Jul 31, 2026: Shares held short 2.01M
- Aug 14, 2026: Shares held short 2.36M
- Aug 31, 2026: Shares held short 1.97M
- Sep 15, 2026: Shares held short 1.64M
- Sep 30, 2026: Shares held short 1.98M
- Oct 15, 2026: Shares held short 2.14M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading69.1% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 69.1% of the shares in the reported trades were short sales, against 52.5% in the 14 before.
- Last 14 sessionsOct 30, 2026 – Nov 18, 2026
- 69.1%
- The 14 beforeOct 12, 2026 – Oct 29, 2026
- 52.5%
- Change
- +16.6 pts
- Short sales a dayon average, of 696.9K shares
- 481.9K
- More than atof 3,656 US-listed companies, same days
- 97%
- Median of alleight in ten from 34.4% to 63.7%
- 50.3%
- Short sales
- Oct 12, 2026: Short sales 49.6%
- Oct 13, 2026: Short sales 49.9%
- Oct 14, 2026: Short sales 70.1%
- Oct 15, 2026: Short sales 79.3%
- Oct 16, 2026: Short sales 56.6%
- Oct 19, 2026: Short sales 53.7%
- Oct 20, 2026: Short sales 34.9%
- Oct 21, 2026: Short sales 56.6%
- Oct 22, 2026: Short sales 42.6%
- Oct 23, 2026: Short sales 42.7%
- Oct 26, 2026: Short sales 50.1%
- Oct 27, 2026: Short sales 52%
- Oct 28, 2026: Short sales 33%
- Oct 29, 2026: Short sales 38.4%
- Oct 30, 2026: Short sales 44.9%
- Nov 2, 2026: Short sales 43.1%
- Nov 3, 2026: Short sales 73.3%
- Nov 4, 2026: Short sales 55.2%
- Nov 5, 2026: Short sales 45.3%
- Nov 6, 2026: Short sales 81.2%
- Nov 9, 2026: Short sales 64.7%
- Nov 10, 2026: Short sales 58.4%
- Nov 11, 2026: Short sales 60.7%
- Nov 12, 2026: Short sales 51.5%
- Nov 13, 2026: Short sales 60.1%
- Nov 16, 2026: Short sales 57.4%
- Nov 17, 2026: Short sales 71.6%
- Nov 18, 2026: Short sales 61.9%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- & Johnson JohnsonTenPercentOwnerDirectly–
- Johnson & Johnson Innovation - JJDC, Inc.TenPercentOwnerDirectly–
- Kirk G. NielsenDirectorDirectly8,720
- Mudit K. JainDirectorDirectly14.4K
- Kevin HykesPRES & CEODirectly284.2K
- Jared OasheimCHIEF FINANCIAL OFFICERDirectly96.7K
- Robert Allen JohnChief Revenue OfficerDirectly86.0K
- Philip B. AdamsonChief Medical OfficerDirectly61.6K
- Paul VerrastroCHIEF MKTG & STRAT OFFICERDirectly60.6K
- Brent BinkowskiCHIEF OPERATING OFFICERDirectly56.5K
- John LandryChief Financial OfficerDirectly41.4K
- Joseph P SlatteryDirectorDirectly39.4K
- Michael D DaleDirectorDirectly29.0K
- Hill, Mitch C.DirectorDirectly8,720
- Kevin J. BallingerDirectorDirectly8,720
- Martha ShadanDirectorDirectly8,720
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| & Johnson JohnsonTenPercentOwner | – | 4.04M | Nov 26, 2025 | Form 4 |
| Johnson & Johnson Innovation - JJDC, Inc.TenPercentOwner | – | 4.02M | Nov 26, 2025 | Form 4 |
| Kirk G. NielsenDirector | 8,720 | 1.91M | Jun 1, 2026 | Form 4 |
| Mudit K. JainDirector | 14.4K | 980.2K | Jun 1, 2026 | Form 4 |
| Kevin HykesPRES & CEO | 284.2K | – | Mar 2, 2026 | Form 4 |
| Jared OasheimCHIEF FINANCIAL OFFICER | 96.7K | – | Mar 2, 2026 | Form 4 |
| Robert Allen JohnChief Revenue Officer | 86.0K | – | Mar 2, 2026 | Form 4 |
| Philip B. AdamsonChief Medical Officer | 61.6K | – | Mar 2, 2026 | Form 4 |
| Paul VerrastroCHIEF MKTG & STRAT OFFICER | 60.6K | – | Mar 2, 2026 | Form 4 |
| Brent BinkowskiCHIEF OPERATING OFFICER | 56.5K | – | Aug 13, 2026 | Form 4 |
| John LandryChief Financial Officer | 41.4K | – | Nov 9, 2026 | Form 4 |
| Joseph P SlatteryDirector | 39.4K | – | Jun 1, 2026 | Form 4 |
| Michael D DaleDirector | 29.0K | – | Jun 1, 2026 | Form 4 |
| Hill, Mitch C.Director | 8,720 | – | Jun 1, 2026 | Form 4 |
| Kevin J. BallingerDirector | 8,720 | – | Jun 1, 2026 | Form 4 |
| Martha ShadanDirector | 8,720 | – | Jun 1, 2026 | Form 4 |
A lower bound: it counts only the 16 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.02%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.01%
- IWMiShares Russell 2000 ETFWeight in the fund0.00%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.00%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
- DFACDimensional U.S. Core Equity 2 ETFWeight in the fund0.00%
- IWViShares Russell 3000 ETFWeight in the fund0.00%
9 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 93
- Q4 2025: Managers 92
- Q1 2026: Managers 100
- Q2 2026: Managers 88
Institutional investors by quarter
The fund managers holding CVRX, quarter by quarter, from Q2 2021 to Q2 2025, 17 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 88 managers held 15.29M shares, worth $79M. During the quarter 9 opened a position, 21 closed one, 34 added and 27 trimmed.
The largest holders, Q2 2026
- Johnson & JohnsonIn the quarter
- NEA ManagementIn the quarter-3.5%
- BlackRockIn the quarter+21%
- Royal Bank of CanadaIn the quarter+74%
- GskIn the quarter
- Vanguard Capital ManagementIn the quarter
- Silvercrest Asset Management GroupIn the quarter+54%
- Geode Capital ManagementIn the quarter+3.2%
- PFM Health SciencesIn the quarter
- State StreetIn the quarter+4.5%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Johnson & Johnson | 4.02M | $21M | |
| NEA Management | 1.95M | -3.5% | $10M |
| BlackRock | 1.25M | +21% | $6.4M |
| Royal Bank of Canada | 1.23M | +74% | $6.3M |
| Gsk | 1.01M | $5.2M | |
| Vanguard Capital Management | 910.6K | $4.7M | |
| Silvercrest Asset Management Group | 878.1K | +54% | $4.5M |
| Geode Capital Management | 440.8K | +3.2% | $2.3M |
| PFM Health Sciences | 369.6K | $1.9M | |
| State Street | 366.4K | +4.5% | $1.9M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do CVRx's filings show?
Who buys and sells is one part of CVRx's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have CVRX's insiders bought or sold?
From Jun 3, 2026 to Nov 12, 2026 CVRx's insiders bought $76.4K and sold $3.3K of shares on the market. 100% of the sales were under set 10b5-1 plans.
Which well-known managers hold CVRX?
6 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $1.1M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.